Profil
Andrew James Webb is currently the Chief Executive Officer & Director at Extruded Pharmaceuticals Ltd.
and the Chief Executive Officer at CRISM Therapeutics Corp.
He is also a Director at Novel Technologies Holdings Ltd.
since 2017.
Previously, he was a Director at Convert2Green Ltd.
Postes actifs de Andrew James Webb
| Sociétés | Poste | Début |
|---|---|---|
Novel Technologies Holdings Ltd.
 Novel Technologies Holdings Ltd. Financial ConglomeratesFinance Novel Technologies Holdings Ltd. operates as an investment holding company. The company was founded on May 24, 2017 and is headquartered in Manchester, the United Kingdom. | Directeur/Membre du Conseil | 23/11/2017 |
Anciens postes connus de Andrew James Webb
| Sociétés | Poste | Fin |
|---|---|---|
Convert2Green Ltd.
 Convert2Green Ltd. Agricultural Commodities/MillingProcess Industries Convert2Green Ltd. provides renewable fuel solution. The company was founded on October 10, 2006 and is headquartered in Shrewsbury, the United Kingdom. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Convert2Green Ltd.
Convert2Green Ltd. Agricultural Commodities/MillingProcess Industries Convert2Green Ltd. provides renewable fuel solution. The company was founded on October 10, 2006 and is headquartered in Shrewsbury, the United Kingdom. | Process Industries |
Novel Technologies Holdings Ltd.
Novel Technologies Holdings Ltd. Financial ConglomeratesFinance Novel Technologies Holdings Ltd. operates as an investment holding company. The company was founded on May 24, 2017 and is headquartered in Manchester, the United Kingdom. | Finance |
